07.05.2023, 2968 Zeichen

Kontron: IoT company Kontron AG has closed the first quarter of 2023 with strong results. After its strategic realignment in 2022 towards the flourishing "Internet of Things" (IoT) the technology group is now powering ahead. With revenue rising to EUR 277.7 million in the first quarter (PY: EUR 247.0 million), revenue growth is at 11.2%, with organic growth as high as 14.0%. EBITDA climbed to EUR 29.6 million (PY: EUR 23.7 million) representing a plus of 24.9%. Net profit increased by 66% to EUR 16.6 million (PY: EUR 10.0 million). A net profit totalling EUR 66 million is expected for the full financial year 2023. The good earnings were driven by the "Software + Solutions" segment, which achieved an EBITDA margin of 18.9%. A record order intake here – the book-to-bill ratio for this segment stood at 219% – suggests strong ongoing growth. Hannes Niederhauser, CEO of Kontron AG: "We expect 2023 to be a very good year for Kontron. With an order backlog of EUR 1,573 million at the end of March, all planned revenue – the target is EUR 1,200 million – for the financial year 2023 has already been secured." 
Kontron: weekly performance: 7.14%

Valneva: Valneva, a specialty vaccine company,  reported its first quarter financial results ending March 31, 2023. Valneva’s total revenues were €33.5 million in the first quarter of 2023 compared to €21.8 million in the first quarter of 2022, an increase of 53.4%. Valneva recorded an operating loss of €16.6 million in the first quarter of 2023 compared to an operating loss of €18.4 million in the first quarter of 2022. Adjusted EBITDA loss in the first quarter of 2023 was €12.3 million compared to an Adjusted EBITDA loss of €13.3 million in the first quarter of 2022. Peter Bühler, Valneva’s Chief Financial Officer, commented, “We entered 2023 with good momentum as we managed to double our first quarter vaccine sales year-over-year, keeping us on track to deliver on our full year sales guidance of €130 million to 150 million. Our objective is to continue driving these sales in 2023 and, at the same time, continue to build a stronger vaccine portfolio and pipeline. As we approach our ten-year anniversary, we look forward to celebrating another major milestone with the potential approval of our chikungunya vaccine candidate in the U.S. later this year.”
Valneva: weekly performance: 34.73%

Wolftank: Wolftank Group, specializing in technologies for energy and environmental solutions, has signed cooperation agreements with several leading e-mobility providers in Italy to install over 400 mainly fast charging stations. The Group is thus taking advantage of the high potential offered by the e-mobility sector and applying its long-standing expertise in the expansion of zero-emission refueling infrastructure. Revenues of around EUR 4 million are expected for these projects.
Wolftank-Adisa: weekly performance: -8.01%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (04/05/2023)

Christian Drastil: Wiener Börse Plausch

Wiener Börse Party #744: Gehen und Kommen - Andreas Gerstenmayer, (AT&S-CEO bleibt noch 1 Woche), Martina Geisler, Oliver Riedel

Bildnachweis

Aktien auf dem Radar:Mayr-Melnhof, Immofinanz, Erste Group, Addiko Bank, Flughafen Wien, Kapsch TrafficCom, ATX, ATX Prime, ATX TR, Wienerberger, Andritz, SBO, ams-Osram, AT&S, Cleen Energy, Marinomed Biotech, Wiener Privatbank, Oberbank AG Stamm, Pierer Mobility, Agrana, Amag, CA Immo, EVN, OMV, Österreichische Post, S Immo, Telekom Austria, Uniqa, VIG.

---